These observations have important implications in metabolic syndrome, where loss of insulin receptiveness could differentially affect the ability of tumor infiltrating immune cell populations to compete with tumor cells for limiting nutrients and resources within the tumor microenvironment, leading to impaired anti-tumor function (157, 158). Here, INS is linked to neoplasm.